Strides Pharma Science Limited (STAR) - Total Assets

Latest as of March 2026: Rs69.27 Billion INR ≈ $749.15 Million USD

Based on the latest financial reports, Strides Pharma Science Limited (STAR) holds total assets worth Rs69.27 Billion INR (≈ $749.15 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Strides Pharma Science Limited - Total Assets Trend (2005–2026)

This chart illustrates how Strides Pharma Science Limited's total assets have evolved over time, based on quarterly financial data. Also see Strides Pharma Science Limited (STAR) total market value for the company's overall valuation and market capitalisation.

Strides Pharma Science Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Strides Pharma Science Limited's total assets of Rs69.27 Billion consist of 52.2% current assets and 47.9% non-current assets. Review STAR current and long-term liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	3.1%
Accounts Receivable	Rs12.97 Billion	18.7%
Inventory	Rs16.35 Billion	23.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs8.00 Billion	11.5%
Goodwill	Rs5.94 Billion	8.6%

Asset Composition Trend (2005–2026)

This chart illustrates how Strides Pharma Science Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Strides Pharma Science Limited for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Strides Pharma Science Limited's current assets represent 52.2% of total assets in 2026, an increase from 47.1% in 2005.
Cash Position: Cash and equivalents constituted 3.1% of total assets in 2026, down from 4.4% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 4.0% in 2005.
Asset Diversification: The largest asset category is inventory at 23.6% of total assets.

Strides Pharma Science Limited Competitors by Total Assets

Key competitors of Strides Pharma Science Limited based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Strides Pharma Science Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.25	1.20	1.03
Quick Ratio	0.68	0.70	0.59
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs7.17 Billion	Rs5.07 Billion	Rs814.64 Million

Strides Pharma Science Limited - Advanced Valuation Insights

This section examines the relationship between Strides Pharma Science Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.96
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	14.5%
Total Assets	Rs69.27 Billion
Market Capitalization	$1.22 Billion USD

Valuation Analysis

Below Book Valuation: The market values Strides Pharma Science Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Strides Pharma Science Limited's assets grew by 14.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Strides Pharma Science Limited (2005–2026)

The table below shows the annual total assets of Strides Pharma Science Limited from 2005 to 2026.

Year	Total Assets	Change
2026-03-31	Rs69.27 Billion ≈ $749.15 Million	+14.52%
2025-03-31	Rs60.49 Billion ≈ $654.15 Million	+3.58%
2024-03-31	Rs58.40 Billion ≈ $631.55 Million	-12.03%
2023-03-31	Rs66.38 Billion ≈ $717.92 Million	-4.84%
2022-03-31	Rs69.76 Billion ≈ $754.41 Million	-0.56%
2021-03-31	Rs70.15 Billion ≈ $758.65 Million	+14.03%
2020-03-31	Rs61.52 Billion ≈ $665.29 Million	-23.16%
2019-03-31	Rs80.06 Billion ≈ $865.77 Million	+22.34%
2018-03-31	Rs65.44 Billion ≈ $707.68 Million	-19.38%
2017-03-31	Rs81.17 Billion ≈ $877.80 Million	+5.98%
2016-03-31	Rs76.59 Billion ≈ $828.30 Million	+208.08%
2015-03-31	Rs24.86 Billion ≈ $268.86 Million	+18.44%
2014-03-31	Rs20.99 Billion ≈ $227.00 Million	-56.25%
2013-03-31	Rs47.98 Billion ≈ $518.84 Million	-12.20%
2012-03-31	Rs54.64 Billion ≈ $590.93 Million	+21.61%
2011-03-31	Rs44.93 Billion ≈ $485.94 Million	+39.12%
2010-03-31	Rs32.30 Billion ≈ $349.29 Million	+38.77%
2009-03-31	Rs23.27 Billion ≈ $251.70 Million	+14.46%
2008-03-31	Rs20.33 Billion ≈ $219.91 Million	+65.73%
2007-03-31	Rs12.27 Billion ≈ $132.69 Million	+31.10%
2006-03-31	Rs9.36 Billion ≈ $101.22 Million	+71.20%
2005-03-31	Rs5.47 Billion ≈ $59.12 Million	--

About Strides Pharma Science Limited

NSE:STAR India Drug Manufacturers - Specialty & Generic

Market Cap

$1.22 Billion

Rs112.43 Billion INR

Market Cap Rank

#8114 Global

#403 in India

Share Price

Rs1219.80

Change (1 day)

+1.63%

52-Week Range

Rs793.55 - Rs1219.80

All Time High

Rs1643.30